Birdwatch Note
2021-09-02 17:55:37 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
While Invermectin is not approved by the FDA to treat COVID-19, the current approved use cases are detailed here: https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19 Emphasizing its veterinary use gives the impression that Invermectin isn’t used in human medicine and contributes to public distrust of media agencies.
Written by B0EF52C1948DAED009E37136F0294AB4
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1433235537205268484
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1433488798726475780
- noteId - 1433488798726475780
- participantId - B0EF52C1948DAED009E37136F0294AB4
- noteAuthorParticipantId -
- createdAtMillis - 1630605337212
- tweetId - 1433235537205268484
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_MANY
- harmful - CONSIDERABLE_HARM
- validationDifficulty - EASY
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- While Invermectin is not approved by the FDA to treat COVID-19, the current approved use cases are detailed here: https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19 Emphasizing its veterinary use gives the impression that Invermectin isn’t used in human medicine and contributes to public distrust of media agencies.
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2021-09-02 17:55:37 UTC (1630605337212) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
CURRENTLY_RATED_HELPFUL | 1969-12-31 23:59:59 UTC (-1) |
7C787A9A5B052DDDBC3D255515FF8CCC1FCF17297EEC8034CB693914AEC5271B | ||
2021-09-02 17:55:37 UTC (1630605337212) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
CURRENTLY_RATED_HELPFUL | 1969-12-31 23:59:59 UTC (-1) |
B0EF52C1948DAED009E37136F0294AB4 |
Note Ratings
rated at | rated by | |
2021-09-02 18:48:25 -0500 | 0378F20DFECC73D3AD98390D25AA66E2BCCAAB4A22DEE65AB440D4CB6446B2E7 | Rating Details |
2021-09-04 17:50:16 -0500 | 078E4B8EF60A7AB13B8204479F1AFF94 | Rating Details |
2021-09-02 16:59:19 -0500 | 0A10E4274F0800BE26D7A149A149A0FF | Rating Details |
2021-09-02 16:59:19 -0500 | 10BDEC89BF7BB928FBE23650C53BEA12FBF17809EA7DE152B98ADEB3E8D2C044 | Rating Details |
2021-09-02 19:52:58 -0500 | 13B400DB04AFD8974DDA29778FAEF60C | Rating Details |
2021-09-04 07:50:53 -0500 | 16CFB95C4212BA4358E6E43B5407FBF1 | Rating Details |
2021-09-02 22:54:38 -0500 | 238938F8A35959DAFA9518817DEB65AA | Rating Details |
2021-09-02 14:22:26 -0500 | 275545B486AE904EA7F4249F17444BBC856538762147559B3AC8EB1478E2EB43 | Rating Details |
2021-09-02 15:01:51 -0500 | 29927B07D0EE89F19DED97265F0CA9DFAD51148414C6C9DEC592E21DF90DCACF | Rating Details |
2022-05-25 10:00:21 -0500 | 306C001FB157171615E1F826F2B1DC71 | Rating Details |
2021-09-02 16:54:50 -0500 | 39334B881B90D4C00C3BF41EC4386349CCE10A523E110AD1FE030BBD4C84C38C | Rating Details |
2021-09-09 14:49:26 -0500 | 3D8937C8D4CA66F90A71B6441E253133F637D96FB749C3ACDFEF6E8B1BBA8E14 | Rating Details |
2021-09-02 14:11:55 -0500 | 46D893DFC474111C12B5EF54ADED5291021E07B5BC4D944EB4F35D18A93785C7 | Rating Details |
2021-09-02 14:24:48 -0500 | 5162497D09C4499EE3A45510E9C21DC5 | Rating Details |
2021-09-02 13:09:18 -0500 | 59E309CBD706512BEDB1360D7D396AD73BD1FBD4A0BCD7F93A13192854DD0310 | Rating Details |
2021-09-02 18:23:13 -0500 | 5B94A2B93D34E3319642DBCA614F427E534814CC0EE0CEFDA763440AB4627ADB | Rating Details |
2021-09-03 16:33:17 -0500 | 601B2AC0F9F51643A2CD37510993AF00 | Rating Details |
2021-09-02 18:09:59 -0500 | 62CA38EE94AC8F23D0B4F3ED5AD6CB079C7A0C68FD9C03CB17ABD72835B67032 | Rating Details |
2021-09-02 20:03:24 -0500 | 6CFA4422F98FA11974DC28938746744A | Rating Details |
2021-09-02 16:54:50 -0500 | 6E868D0E6E04B54D297CBAE4990550E6 | Rating Details |
2021-09-04 17:50:16 -0500 | 714A75455F14B87E70AF9588E5234B01C78A62AE1BB949354AB937F0CFF4D6DC | Rating Details |
2021-09-02 14:22:51 -0500 | 774C93731BBA61C77F28BF18A899DA528A4D9CB29CDD7BA7CE27C38D7C3353E2 | Rating Details |
2022-05-25 10:00:21 -0500 | 7ACFC241269ACF463C8AFEC7B840E5BE0F5AD92BBFA3C42757299F9311499390 | Rating Details |
2021-09-02 14:46:15 -0500 | 811A1F1B467069186BADCDA65CD8C755 | Rating Details |
2022-04-02 00:49:53 -0500 | 8287473C23000581E5B9AA8BA49800DB | Rating Details |
2021-09-02 18:23:13 -0500 | 833DB7A8DD53BB58009275B560A225CA | Rating Details |
2021-09-09 14:49:26 -0500 | 86D87C6A32C0F45008E1704F32AD4BE3 | Rating Details |
2021-09-02 22:54:38 -0500 | 9736DF42171A999208E640D9616E3AF1D2219C9694E38F806D374F891F58485E | Rating Details |
2021-09-02 18:48:25 -0500 | A8CB5D5E5A53FEA286C15D44FBE39BF6 | Rating Details |
2021-09-02 14:46:15 -0500 | AD2E30976CCEEC611C081FCCC4124F135217FD86BDB79987D8C424145FC3DFE2 | Rating Details |
2021-09-02 14:22:26 -0500 | B0A598177115ED06AA33E955ACAC04DD | Rating Details |
2021-09-02 14:22:51 -0500 | BAA2E57EBC7D6FF2035BF0CFF542D53B | Rating Details |
2021-09-02 20:03:24 -0500 | BABACC5B9028212797428199F62202CBA230422BAE751B529CAB650DCD177686 | Rating Details |
2021-09-02 13:09:18 -0500 | BB627376C1CA1EF733556BD4297F265D | Rating Details |
2021-09-04 07:50:53 -0500 | C46BD788C8E4311935178446476A31C8A5E46D54482EE5DF1CDA14A30AFE51B8 | Rating Details |
2021-09-02 18:09:59 -0500 | D9D6381D990A005CE585D0A306B35233 | Rating Details |
2021-09-02 14:11:55 -0500 | DB835EE09E208271F1AE42AA00D8490D | Rating Details |
2021-09-02 15:01:51 -0500 | DE8C4D375F6CACCFDD1C659DD41BAD4E | Rating Details |
2021-09-02 19:52:58 -0500 | E0AA7F473BCA220F74D45FC42C52DE18DF0193BF8E0143E52659601884F2C60B | Rating Details |
2022-04-02 00:49:53 -0500 | EEA39E8B4AB1BEFA47B775A2CE4DCDDD073841F27C81F5E281FC7C6F7F045296 | Rating Details |
2021-09-02 14:24:48 -0500 | F2E6F31DCC90CA2AD656E1D3B85EB7CFAD77FB78F57C8DB6892EED3A0EE0DFA5 | Rating Details |
2021-09-03 16:33:17 -0500 | F9AE853DA20AF913CAD1A524778ED24BA23B106CCC952D1293EA2FAB40448878 | Rating Details |
2021-09-02 14:11:55 -0500 | Rating Details | |
2021-09-02 13:09:18 -0500 | Rating Details | |
2022-04-02 00:49:53 -0500 | Rating Details | |
2022-05-25 10:00:21 -0500 | Rating Details | |
2021-09-02 20:03:24 -0500 | Rating Details | |
2021-09-03 16:33:17 -0500 | Rating Details | |
2021-09-02 22:54:38 -0500 | Rating Details | |
2021-09-02 14:22:26 -0500 | Rating Details | |
2021-09-02 18:23:13 -0500 | Rating Details | |
2021-09-02 14:22:51 -0500 | Rating Details | |
2021-09-02 16:59:19 -0500 | Rating Details | |
2021-09-02 14:24:48 -0500 | Rating Details | |
2021-09-02 16:54:50 -0500 | Rating Details | |
2021-09-02 15:01:51 -0500 | Rating Details | |
2021-09-09 14:49:26 -0500 | Rating Details | |
2021-09-02 18:09:59 -0500 | Rating Details | |
2021-09-02 19:52:58 -0500 | Rating Details | |
2021-09-02 14:46:15 -0500 | Rating Details | |
2021-09-04 17:50:16 -0500 | Rating Details | |
2021-09-02 18:48:25 -0500 | Rating Details | |
2021-09-04 07:50:53 -0500 | Rating Details |